[go: up one dir, main page]

DE60018881D1 - Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen - Google Patents

Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen

Info

Publication number
DE60018881D1
DE60018881D1 DE60018881T DE60018881T DE60018881D1 DE 60018881 D1 DE60018881 D1 DE 60018881D1 DE 60018881 T DE60018881 T DE 60018881T DE 60018881 T DE60018881 T DE 60018881T DE 60018881 D1 DE60018881 D1 DE 60018881D1
Authority
DE
Germany
Prior art keywords
extract
herb
mother
extracts
inflammatory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018881T
Other languages
English (en)
Other versions
DE60018881T2 (de
Inventor
Theresa Callaghan
Thierry Oddos
J Gendimenico
Katharine Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Holdings France SAS
Original Assignee
Johnson and Johnson Consumer France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60018881(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson and Johnson Consumer France SAS filed Critical Johnson and Johnson Consumer France SAS
Application granted granted Critical
Publication of DE60018881D1 publication Critical patent/DE60018881D1/de
Publication of DE60018881T2 publication Critical patent/DE60018881T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Cosmetics (AREA)
DE60018881T 1999-06-03 2000-06-02 Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen Expired - Lifetime DE60018881T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13733299P 1999-06-03 1999-06-03
US137332P 1999-06-03
PCT/US2000/015125 WO2000074699A1 (en) 1999-06-03 2000-06-02 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders

Publications (2)

Publication Number Publication Date
DE60018881D1 true DE60018881D1 (de) 2005-04-28
DE60018881T2 DE60018881T2 (de) 2006-02-16

Family

ID=22476913

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60018881T Expired - Lifetime DE60018881T2 (de) 1999-06-03 2000-06-02 Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen

Country Status (14)

Country Link
US (1) US6410062B1 (de)
EP (1) EP1100516B1 (de)
JP (1) JP2004500329A (de)
KR (1) KR100755798B1 (de)
CN (1) CN1319020A (de)
AT (1) ATE291433T1 (de)
AU (1) AU778261B2 (de)
BR (1) BRPI0006634B8 (de)
CA (1) CA2339221C (de)
DE (1) DE60018881T2 (de)
ES (1) ES2239010T3 (de)
MX (1) MXPA01001327A (de)
PT (1) PT1100516E (de)
WO (1) WO2000074699A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
EP1367993B1 (de) * 2001-03-16 2007-05-16 Johnson & Johnson Consumer Companies, Inc. Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
US20030077343A1 (en) 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20020185426A1 (en) * 2001-04-26 2002-12-12 Bealer Leroy J. Environmental flexible remediation system
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
MY139332A (en) * 2002-05-22 2009-09-30 Hovid Berhad Hair growth formulation
WO2004037237A1 (en) 2002-10-24 2004-05-06 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040161436A1 (en) * 2003-02-13 2004-08-19 Hull Barbara A. Skin treatment composition and method
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US20050003025A1 (en) * 2003-06-30 2005-01-06 Hargens Robert D. Method of mitigating the odor of valerian extracts
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7758902B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
JP4903569B2 (ja) * 2003-09-12 2012-03-28 アクセス ビジネス グループ インターナショナル エルエルシー サイトカインモジュレータ及び関係する使用法
EP1543822A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Soja enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
EP1543823A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingkoextrakt enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
US20050244480A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Pre-wipes for improving anal cleansing
US20060003654A1 (en) * 2004-06-30 2006-01-05 Lostocco Michael R Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers
US20060147484A1 (en) * 2005-01-03 2006-07-06 Hestand Mark A Urushiol-induced contact dermatitis composition, method of use, and method of manufacture
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
WO2006128169A2 (en) * 2005-05-26 2006-11-30 The Ohio State University Research Foundation Inhibition of monocyte survival, differentiation, or proliferation
WO2008140440A1 (en) * 2005-12-07 2008-11-20 Mmp International Development And Manufacturing Stable flavonoid solutions
NZ607880A (en) * 2006-02-21 2014-11-28 Akzo Nobel Surface Chemistry Llc Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
CN101406514B (zh) * 2007-10-10 2011-03-23 徐柔云 一种治疗脚癣的外用药
JP2010013403A (ja) * 2008-07-04 2010-01-21 Kao Corp Ｎｆａｔシグナル阻害剤及びｎｆａｔシグナル阻害方法
FR2940127B1 (fr) * 2008-12-18 2013-07-12 Nolva Lab Compositions a usage cosmetique et dermatologique destinees a lutter contre le vieillissement de la peau et contenant un extrait titre de ginkgo biloba et un extrait purifie de lactoferrine
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
US8075931B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8075930B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8916209B2 (en) * 2009-10-02 2014-12-23 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
WO2011109259A1 (en) 2010-03-01 2011-09-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
US20110262505A1 (en) * 2010-04-22 2011-10-27 Gina Athwal Seaweed-derived cosmetic compositions
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9173913B2 (en) * 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9724315B2 (en) * 2011-09-30 2017-08-08 Cmpd Licensing, Llc Compounded transdermal pain management
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US9468599B2 (en) 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
FR3015299B1 (fr) * 2013-12-20 2017-10-06 Oreal Dispositif d'iontophorese a gestion independante de courant
US10352605B2 (en) * 2017-02-14 2019-07-16 Heatcraft Refrigerator Products, LLC Cooling system with intermediate heat exchange fluid loop
KR102157755B1 (ko) * 2018-12-28 2020-09-18 경희대학교 산학협력단 운카리나 스텔루리페라 추출물을 유효성분으로 포함하는 항염증 또는 항아토피 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
US6103218A (en) 1997-04-23 2000-08-15 Brucker; Donald Therapeutic nasal spray administered composition containing feverfew
BR9811789A (pt) * 1997-09-12 2000-09-05 Procter & Gamble Artigo de limpeza e condicionamento para tratamento pessoal de utilização única, descartável e processos para manufaturar esse artigo e para limpar e condicionar a pele ou cabelo com esse artigo

Also Published As

Publication number Publication date
CA2339221C (en) 2013-09-10
CA2339221A1 (en) 2000-12-14
KR100755798B1 (ko) 2007-09-07
EP1100516A1 (de) 2001-05-23
DE60018881T2 (de) 2006-02-16
ES2239010T3 (es) 2005-09-16
EP1100516B1 (de) 2005-03-23
JP2004500329A (ja) 2004-01-08
BRPI0006634B1 (pt) 2015-06-02
MXPA01001327A (es) 2002-11-29
CN1319020A (zh) 2001-10-24
BRPI0006634B8 (pt) 2021-05-25
PT1100516E (pt) 2005-07-29
ATE291433T1 (de) 2005-04-15
WO2000074699A1 (en) 2000-12-14
US6410062B1 (en) 2002-06-25
AU5313000A (en) 2000-12-28
BR0006634A (pt) 2001-05-02
KR20010072221A (ko) 2001-07-31
AU778261B2 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60018881D1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
ATE419858T1 (de) Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
SE9804000D0 (sv) New composition of matter
DE60322436D1 (de) Verabreichung von capsaicinoiden
DE60229971D1 (de) Zubereitungen zur reizhemmenden rosacea-behandlung
BR9916694A (pt) Composição de lenço facial e método de uso parasequestração de irritantes cutâneos de secreçãonasal
EP1605956A4 (de) Verabreichung von capsaicinoiden
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
NO993847D0 (no) Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
DK1089744T3 (da) Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
DK0909556T3 (da) Rosaceae-ekstrakt som bradykininantagonist
NO20050718L (no) Topikal behandling av hudsykdommer
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BRPI0411324A (pt) composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes
ATE326947T1 (de) Thixotropes nasenspray
BR0314713A (pt) Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
DE69419854D1 (de) Arzneimittelzusammensetzung zur Prophylaxe und Behandlung vorzeitigen Samenergusses
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
ATE289515T1 (de) Extrakte aus selleriesamen zur vorbeugung und behandlung von entzündungen und gastrointestinalen irritationen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition